Early preeclampsia associated with hydatidiform mole and pulmonary metastasis: A case report

Main Article Content

Daniel Anuar Rivera Hernández https://orcid.org/0009-0005-1242-8770
Lenyn Daniel Montes-Sevilla https://orcid.org/0009-0005-1900-4452
Dennis Ximena Murcia Acero https://orcid.org/0009-0007-2087-0037
Ana Lilia Castillo Medina https://orcid.org/0009-0009-6837-239X

Keywords

Pre-Eclampsia, Hydatidiform Mole, Gestational Trophoblastic Disease, Chorionic Gonadotropin, beta Subunit, Human, Pregnancy in adolescence

Abstract

Abstract


Background: Preeclampsia before 20 weeks of gestation is an unusual clinical entity that suggests an underlying etiology, such as gestational trophoblastic disease (GTD). Among its forms, complete hydatidiform mole may evolve into gestational trophoblastic neoplasia with metastatic potential. The objective was to present the case of an adolescent patient with early-onset preeclampsia as the initial manifestation of a complete hydatidiform mole with pulmonary metastasis.


Clinical case: A 15-year-old patient without prenatal care was admitted due to vaginal bleeding, persistent nausea, and clinical signs of preeclampsia. A complete hydatidiform mole associated with grade IV hypovolemic shock was diagnosed. Patient underwent urgent uterine evacuation, intensive care for uterine atony, and received EMA-CO chemotherapy after pulmonary metastases were identified. 3 months after completing treatment, a viable intrauterine pregnancy was confirmed, with no evidence of tumor recurrence.


Conclusions: The onset of preeclampsia before 20 weeks should raise suspicion of GTD. Timely, multidisciplinary management can achieve full disease resolution, preserve fertility, and avoid long-term sequelae, even in advanced clinical scenarios.

Abstract 51 | PDF (Spanish) Downloads 137

References

1. Ngan HYS, Seckl MJ, Berkowitz RS, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155 Suppl 1(Suppl 1):86-93. doi: 10.1002/ijgo.13877

2. Jung E, Romero R, Yeo L, et al. The etiology of preeclampsia. Am J Obstet Gynecol. 2022;226(2S):S844-66. doi: 10.1016/j.ajog.2021.11.1356

3. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-92. doi: 10.1016/S0029-7844(03)00475-7

4. Zhao M, Yin Y, Guo F, et al. Placental expression of VEGF is increased in pregnancies with hydatidiform mole: Possible association with developing very early onset preeclampsia. Early Hum Dev. 2013;89(8):583-8. doi: 10.1016/j.earlhumdev.2013.02.008

5. Lu B, Ma Y, Shao Y, et al. Twin pregnancy with complete hydatidiform mole and co-existing fetus: A report of 15 cases with a clinicopathological analysis and DNA genotyping. Pathol Res Pract. 2022;238:154116. doi: 10.1016/j.prp.2022.154116

6. Vogin G, Golfier F, Hajri T, et al. A HELLP syndrome complicates a gestational trophoblastic neoplasia in a perimenopausal woman: a case report. BMC Cancer. 2016;16(1):573. doi: 10.1186/s12885-016-2641-2

7. Willy D, Schmitz R, Möllers M, et al. Severe, very early onset preeclampsia in a Covid-19 positive woman with a twin pregnancy presenting with a hydatidiform mole and coexisting normal fetus: a case report. Front Med (Lausanne). 2024;10:1340905. doi: 10.3389/fmed.2024.1340905

8. Abu-Rustum NR, Yashar CM, Bean S, et al. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(11):1374-91. doi: 10.6004/jnccn.2019.0053

9. Lisonkova S, Sabr Y, Mayer C, et al. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol 2014;124(4):771-81. doi: 10.1097/AOG.0000000000000472

10. Xing D, Adams E, Zou YS, et al. Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution. Am J Surg Pathol. 2022;46(9):1180-95. doi: 10.1097/PAS.0000000000001893

11. Chirilă CN, Mărginean C, Chirilă PM, et al. The Current Role of the sFlt-1/PlGF Ratio and the Uterine-Umbilical-Cerebral Doppler Ultrasound in Predicting and Monitoring Hypertensive Disorders of Pregnancy: An Update with a Review of the Literature. Children (Basel). 2023;10(9):1430. doi: 10.3390/children10091430

12. Alemie T, Abebe A, Adal O, et al. Clinical features and outcomes of patients with preeclampsia and eclampsia at Gondar University hospital, Amhara, Ethiopia 2021. Eur J Obstet Gynecol Reprod Biol X. 2023;20:100254. doi: 10.1016/j.eurox.2023.100254

13. Meyers M, Awada A, Najmaoui M, et al. Metastatic Gestational Trophoblastic Neoplasia Leading to Acute Respiratory Failure and Death: A Case Report – About a Particularly Challenging Management in the Intensive Care Unit, and Exploring the Potential of Pembrolizumab in Treating Frail, Pretreated Gestational Trophoblastic Neoplasia. Case Rep Oncol. 2025;18(1):386-97. doi: 10.1159/000543518

14. Hou YM, Li PP, Yu H, et al. Clinical features and demographic characteristics of gestational trophoblastic neoplasia: Single center experience and the SEER database. Biomol Biomed. 2024;24(1):176-87. doi: 10.17305/bb.2023.9092

15. Berkowitz RS, Goldstein DP. Clinical Practice. Molar Pregnancy. N Engl J Med. 2009;360(16):1639-45. doi: 10.1056/NEJMcp0900696

16. Hemida R, Khashaba E, Zalata K. Molar pregnancy with a coexisting living fetus: a case series. BMC Pregnancy Childbirth. 2022;22(1):681. doi: 10.1186/s12884-022-05004-3

17. Joneborg U, Coopmans L, Van Trommel N, et al. Fertility and pregnancy outcome in gestational trophoblastic disease. Int J Gynecol Cancer. 2021;31(3):399-411. doi: 10.1136/ijgc-2020-001784

18. Cioffi R, Bergamini A, Gadducci A, et al. Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy. Int J Gynecol Cancer. 2018;28(2):332-7. doi: 10.1097/IGC.0000000000001175

19. Eiriksson L, Dean E, Sebastianelli A, et al. Guideline No. 408: Management of Gestational Trophoblastic Diseases. J Obstet Gynaecol Can. 2021;43(1):91-105. doi: 10.1016/j.jogc.2020.03.001

20. Gueye M, Ndiaye-Gueye MD, Kane-Gueye SM, et al. Diagnosis, treatment and outcome of gestational trophoblastic neoplasia in a low resource income country. Int J MCH AIDS. 2016;5(2):112-8. doi: 10.21106/ijma.108

21. Mangla M, Rahiman EA, Kaur H, et al. Gestational trophoblastic neoplasia with concurrent metastasis to the mother and child: a systematic literature review. J Turk Ger Gynecol Assoc. 2023;24(3):206-19. doi: 10.4274/jtgga.galenos.2023.2023-5-2

22. Irani RA, Holliman K, Debbink M, et al. Complete Molar Pregnancies with a Coexisting Fetus: Pregnancy Outcomes and Review of Literature. AJP Rep. 2021;12(1):e96-107. doi: 10.1055/a-1678-3563

23. Salazar-Marcatoma L, Osorio-Gutiérrez G, Sarmiento-Sulca S. Mola hidatiforme completa y preeclampsia severa a las 9 semanas de gestación: reporte de un caso. Ciencia Latina Rev Cient Multidiscip. 2022;6(6):14614-27. doi: 10.37811/cl_rcm.v6i4.2985

24. Llivicura-Sucuzhañay JA, Mejía-Campoverde LH. Histerectomía por embarazo molar completo. Reporte de caso. MQR Investigar. 2023;7(3):1208-21. doi: 10.56048/MQR20225.7.3.2023.1208-1221

25. Core D, Vervaeke H, Leethy K, et al. Eclampsia, HELLP and PRES in a 16-week partial molar pregnancy. BMJ Case Rep. 2024;17(6):e258188. doi: 10.1136/bcr-2023-258188

26. Pérez-Nieto OR, Herrera-Venegas CA, Pozos-Cortés KP, et al. A case report of atypical preeclampsia with severity criteria for hydatidiform complete mole. Clin Case Rep. 2023;11(6):e7470. doi: 10.1002/ccr3.7470

27. Saad OE, Tanouti S, Bkiyar H, et al. Near death 18 weeks preeclampsia in molar pregnancy. Int J Reprod Contracept Obstet Gynecol. 2020;9(2):877-80. doi: 10.18203/2320-1770.ijrcog20200399

28. Flores-Acosta CC, Barboza-Quintana O, Vidal-Gutiérrez O, et al. Embarazo ectópico molar cornual: caso clínico. Rev Chil Obstet Ginecol. 2010;75(2):133-6. doi: 10.4067/S0717-75262010000200010

29. Blanco E, Marin M, Nuñez L, et al. Adverse pregnancy and perinatal outcomes in Latin America and the Caribbean: systematic review and meta-analysis. Rev Panam Salud Publica. 2022;46:e21. doi: 10.26633/rpsp.2022.21

30. Shahzadi M, Khan SR, Tariq M, et al. Review of current literature on gestational trophoblastic neoplasia. J Egypt Natl Canc Inst. doi: 10.1186/s43046-023-00195-y

31. Wong JM, Liu D, Lurain JR. Reproductive outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia. J Reprod Med. 2014;59(5-6):204-8.

32. Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009;112(3):654-62. doi: 10.1016/j.ygyno.2008.09.005

33. Hernández-Flores SE, Vega-Memije ME, Niebla-Cárdenas D, et al. Incidencia de enfermedad trofoblástica gestacional en un hospital general. Ginecol Obstet Mex. 2016;84(6):377-82.

34. Márquez-Monter H, Alfaro-de la Vega C, Robles M, et al. Epidemiology and pathology of hydatidiform mole in General Hospital. Am J Obstet Gynecol. 1963;85(6):856-64. doi: 10.1016/S0002-9378(16)35586-7